Trials / Terminated
TerminatedNCT00348634
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- —
Summary
This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegaserod |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2006-07-04
- Last updated
- 2016-03-04
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00348634. Inclusion in this directory is not an endorsement.